Please assess the completion status of the following clinical trial:

Trial Title: Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Subjects affected by HD or those who are at risk for HD by virtue of having a first-degree relative with the illness, methamphetamine abuse or dependence, as well as normal controls, can participate.~* All subjects will be above the age of 21.~* Subjects will be recruited from clinical settings, and will also be self-referred.~Exclusion criteria:~* Individuals with pacemakers, infusion pumps, or metallic shrapnel will be excluded from MRI assessments.~* Such implanted metals may be attracted by the MRI machine and put the individual at risk.~* Moreover, individuals with a history of brain surgery and/or skull fracture will also be excluded.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: None): Subjects with mild or moderate Huntington's Disease
- 2 (Type: None): Normal Controls

Based on this trial design, predict the completion outcome and termination type (if applicable).